CALCIUM CHLORIDE/DEMO SOL.INF 10% W/V Yunani - Yunani - Εθνικός Οργανισμός Φαρμάκων

calcium chloride/demo sol.inf 10% w/v

demo abee 21 ΧΛΜ. ΕΘΝ.ΟΔΟΥ ΑΘΗΝΩΝ-ΛΑΜΙΑΣ, 145 68 145 68, ΚΡΥΟΝΕΡΙ 8161802 - calcium chloride dihydrate - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - 10% w/v - calcium chloride dihydrate 100mg - calcium chloride

SODIUM CHLORIDE/UNI-PHARMA SOL.INF 0.9% W/V Yunani - Yunani - Εθνικός Οργανισμός Φαρμάκων

sodium chloride/uni-pharma sol.inf 0.9% w/v

uni-pharma ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ 14 ΧΛΜ. ΕΘΝ. ΟΔΟΥ ΑΘΗΝΩΝ-ΛΑΜΙΑΣ, 14564 Κ.ΚΗΦΙΣΙΑ 8072534 8072512 - sodium chloride - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - 0.9% w/v - sodium chloride 0,9g - sodium chloride

LINCOMED 300MG/ML SOLUTION FOR INJECTION OR INFUSION Siprus - Yunani - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

lincomed 300mg/ml solution for injection or infusion

medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - lincomycin hydrochloride monohydrate - solution for injection or infusion - 300mg/ml - lincomycin hydrochloride monohydrate (0007179499) 340,2mg - lincomycin

ROBICAINE 2MG/ML SOLUTION FOR INFUSION Siprus - Yunani - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

robicaine 2mg/ml solution for infusion

sapiens pharmaceuticals ltd (0000008387) ierou lochou 39, kapsalos, lemesos, 3082 - ropivacaine hydrochloride - solution for infusion - 2mg/ml - ropivacaine hydrochloride (8000003265) 2mg base - ropivacaine

SODIUM CHLORIDE/DEMO 0.9% W/V SOLUTION FOR INTRAVENOUS INFUSION Siprus - Yunani - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sodium chloride/demo 0.9% w/v solution for intravenous infusion

demo s.a. (0000003568) 21st km national road athens-lamia, krioneri, attiki, 14568 - sodium chloride - solution for intravenous infusion - 0.9% w/v - sodium chloride (0007647145) 9g - sodium chloride

SODIUM CHLORIDE/VIOSER 0.9% W/V SOLUTION FOR INFUSION Siprus - Yunani - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sodium chloride/vioser 0.9% w/v solution for infusion

multi-pharm co ltd (0000010111) 24 apollonos str., nicosia, 1046 - sodium chloride - solution for infusion - 0.9% w/v - sodium chloride (0007647145) 0,9% - sodium chloride

CALCIUM CHLORIDE/COOPER INJ.SOL 10% W/V Yunani - Yunani - Εθνικός Οργανισμός Φαρμάκων

calcium chloride/cooper inj.sol 10% w/v

ΚΟΠΕΡ Α.Ε. ΑΡΙΣΤΟΒΟΥΛΟΥ 64, 11853 Κ. ΠΕΤΡΑΛΩΝΑ 3462102 3462108 - calcium chloride dihydrate - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 10% w/v - calcium chloride dihydrate 100mg - calcium chloride

CALRECIA 100MMOL/L SOLUTION FOR INFUSION Siprus - Yunani - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

calrecia 100mmol/l solution for infusion

fresenius medical care deutschland gmbh (0000001970) else-kroner-str. 1, bad homburg v.d.h., 61352 - calcium chloride dihydrate - solution for infusion - 100mmol/l - calcium chloride dihydrate (0010035048) 14,7g

Sitagliptin / Metformin hydrochloride Mylan Uni Eropa - Yunani - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - Σακχαρώδης διαβήτης τύπου 2 - Φάρμακα που χρησιμοποιούνται στον διαβήτη - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. θεραπεία τριπλού συνδυασμού) ως επιπρόσθετο στη δίαιτα και την άσκηση σε ασθενείς που δεν ελέγχονται επαρκώς με μέγιστη ανεκτή για αυτούς δόση μετφορμίνης και σουλφονυλουρίας. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Vildagliptin / Metformin hydrochloride Accord Uni Eropa - Yunani - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - Σακχαρώδης διαβήτης τύπου 2 - Φάρμακα που χρησιμοποιούνται στον διαβήτη - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 και 5. 1 για διαθέσιμα δεδομένα σχετικά με διαφορετικούς συνδυασμούς).